主管:国家卫生健康委员会
主办:国家卫生健康委医院管理研究所
中国科技核心期刊(中国科技论文统计源期刊)
中国科学引文数据库(CSCD)核心库期刊
《中文核心期刊要目总览》核心期刊

中国护理管理 ›› 2019, Vol. 19 ›› Issue (5): 778-783.doi: 10.3969/j.issn.1672-1756.2019.05.029

• 专科管理 • 上一篇    下一篇

慢性粒细胞白血病患者规范化管理的效果

方云 刘敏杰 张伟伟 程斯 曹兰艳   

  1. 华中科技大学同济医学院附属协和医院血液科,430022 武汉市
  • 出版日期:2019-05-15 发布日期:2019-05-15
  • 通讯作者: 刘敏杰,硕士,主管护师,E-mail:344036860@qq.com E-mail:E-mail:fangyun01@163.com
  • 作者简介:方云,硕士,副主任护师,科护士长,E-mail:fangyun01@163.com
  • 基金资助:
    湖北省财政厅专项基金(02.01.18017)

Effects of Chronic Myelocytic Leukemia standard management program

FANG Yun, LIU Minjie, ZHANG Weiwei, CHENG Si, CAO Lanyan   

  1. Department of Hematology, Union Hospital of Tongji Medical College, Huazhong Universary of Science and Technology, Wuhan, 430022, China
  • Online:2019-05-15 Published:2019-05-15
  • Contact: E-mail:344036860@qq.com E-mail:E-mail:fangyun01@163.com

摘要: 目的:分析慢性粒细胞白血病(Chronic Myelocytic Leukemia,CML)患者规范化管理的方法和效果。方法:便利选取106例确诊为CML的患者,随机分为干预组和对照组各53例。前者采用以Donabedian的结构-过程-结果三维质量模式为理论框架的患者规范化管理服务;后者采用常规护理。结果:干预结束时,干预组的服药依从性优于对照组,差异有统计学意义(t=2.628,P=0.010);两组生活质量(Quality of Life,QOL)比较,差异无统计学意义(t=0.008,?P=0.993)。干预结束后6个月,干预组的服药依从性和QOL均优于对照组,差异有统计学意义(t=8.117,P<0.001;t=2.572,P=0.012)。结论:CML患者规范化管理方案能够有效改善患者的服药依从性和健康相关QOL。

关键词: 慢性粒细胞白血病; 护理管理;Donabedian;结构-过程-结果

Abstract: Objective: To explore the effects of chronic myelocytic leukemia (CML) standard management program based on structure-process-outcome model. Methods: A total of 106 CML patients were randomly assigned to the standard management program group (n=53) and the control group (n=53). On the basis of Donabedian's quality of care program of structure-process-outcome, standardized management service was provided to intervention group, while, the control group received general nursing care. Results: After the intervention, the results indicated that there were significant differences in scores of medication compliance between the two groups (t=2.628, P=0.010); there were no significant differences in Quality of Life (QOL) between the two groups (t=0.008, P=0.993). After six months of the intervention, there were significant differences between the two groups in the medication compliance (t=8.117, P<0.001) and QOL (t=2.572, P=0.012) respectively, with higher scores in the intervention group. Conclusion: Standardized CML management program can effectively improve the medication compliance and QOL in patients with CML.

Key words: Chronic Myelocytic Leukemia; nursing management; Donabedian; structure-process-outcome

中图分类号: 

  • R47